(11-18) 16:08 PST , (AP) -- Pfizer Inc. says it is halting a key study of its experimental blood thinner apixaban because of dangerous bleeding among patients with a history of heart disease. The drug, co-developed with...
By The Associated Press, San Francisco Chronicle: Business
Thu, 11/18/2010 - 5:08pm
(11-18) 16:08 PST , (AP) -- Pfizer Inc. says it is halting a key study of its experimental blood thinner apixaban because of dangerous bleeding among patients with a history of heart disease. The drug, co-developed with...